nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1B—trigeminal nucleus—multiple sclerosis	0.18	0.255	CbGeAlD
Xylometazoline—HTR1D—trigeminal nucleus—multiple sclerosis	0.174	0.247	CbGeAlD
Xylometazoline—HTR1D—meninx—multiple sclerosis	0.116	0.164	CbGeAlD
Xylometazoline—HTR1B—trigeminal nerve—multiple sclerosis	0.0473	0.067	CbGeAlD
Xylometazoline—HTR1D—trigeminal nerve—multiple sclerosis	0.0458	0.0649	CbGeAlD
Xylometazoline—ADRA2A—peripheral nervous system—multiple sclerosis	0.0125	0.0178	CbGeAlD
Xylometazoline—HTR1B—brainstem—multiple sclerosis	0.00741	0.0105	CbGeAlD
Xylometazoline—HTR1D—brainstem—multiple sclerosis	0.00718	0.0102	CbGeAlD
Xylometazoline—ADRA1A—brainstem—multiple sclerosis	0.00552	0.00782	CbGeAlD
Xylometazoline—ADRA1B—nervous system—multiple sclerosis	0.00514	0.00729	CbGeAlD
Xylometazoline—ADRA1D—nervous system—multiple sclerosis	0.00503	0.00713	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—multiple sclerosis	0.00495	0.00702	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—multiple sclerosis	0.00484	0.00686	CbGeAlD
Xylometazoline—HTR1B—midbrain—multiple sclerosis	0.00473	0.0067	CbGeAlD
Xylometazoline—HTR1B—spinal cord—multiple sclerosis	0.00461	0.00653	CbGeAlD
Xylometazoline—HTR1D—midbrain—multiple sclerosis	0.00458	0.00648	CbGeAlD
Xylometazoline—ADRA1B—brain—multiple sclerosis	0.00393	0.00557	CbGeAlD
Xylometazoline—HTR1B—nervous system—multiple sclerosis	0.00388	0.00551	CbGeAlD
Xylometazoline—ADRA1D—brain—multiple sclerosis	0.00385	0.00545	CbGeAlD
Xylometazoline—HTR1D—nervous system—multiple sclerosis	0.00376	0.00533	CbGeAlD
Xylometazoline—HTR1B—central nervous system—multiple sclerosis	0.00374	0.0053	CbGeAlD
Xylometazoline—ADRA2C—medulla oblongata—multiple sclerosis	0.00367	0.00519	CbGeAlD
Xylometazoline—HTR1D—central nervous system—multiple sclerosis	0.00362	0.00513	CbGeAlD
Xylometazoline—ADRA2C—midbrain—multiple sclerosis	0.00335	0.00475	CbGeAlD
Xylometazoline—ADRA2C—spinal cord—multiple sclerosis	0.00327	0.00463	CbGeAlD
Xylometazoline—HTR1B—brain—multiple sclerosis	0.00297	0.00421	CbGeAlD
Xylometazoline—ADRA2A—medulla oblongata—multiple sclerosis	0.00292	0.00414	CbGeAlD
Xylometazoline—ADRA1A—nervous system—multiple sclerosis	0.00289	0.0041	CbGeAlD
Xylometazoline—HTR1D—brain—multiple sclerosis	0.00287	0.00407	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—multiple sclerosis	0.00278	0.00394	CbGeAlD
Xylometazoline—ADRA2C—nervous system—multiple sclerosis	0.00275	0.0039	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—multiple sclerosis	0.00272	0.00385	CbGeAlD
Xylometazoline—ADRA2A—midbrain—multiple sclerosis	0.00267	0.00379	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—multiple sclerosis	0.00265	0.00376	CbGeAlD
Xylometazoline—ADRA2A—spinal cord—multiple sclerosis	0.00261	0.0037	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—multiple sclerosis	0.00259	0.00367	CbGeAlD
Xylometazoline—ADRA1A—brain—multiple sclerosis	0.00221	0.00313	CbGeAlD
Xylometazoline—ADRA2A—nervous system—multiple sclerosis	0.0022	0.00311	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—multiple sclerosis	0.00212	0.003	CbGeAlD
Xylometazoline—ADRA2C—brain—multiple sclerosis	0.0021	0.00298	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—multiple sclerosis	0.00207	0.00293	CbGeAlD
Xylometazoline—ADRA2A—brain—multiple sclerosis	0.00168	0.00238	CbGeAlD
Xylometazoline—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	0.000104	0.000354	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000104	0.000354	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000103	0.000351	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	0.000103	0.000351	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	0.000103	0.000351	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	0.000103	0.00035	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000102	0.000346	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	0.000102	0.000345	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	0.000101	0.000344	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	0.000101	0.000344	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	0.0001	0.000341	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	9.96e-05	0.000338	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	9.95e-05	0.000338	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CD86—multiple sclerosis	9.91e-05	0.000337	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	9.89e-05	0.000336	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	9.86e-05	0.000335	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	9.84e-05	0.000334	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	9.75e-05	0.000331	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	9.73e-05	0.000331	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	9.72e-05	0.00033	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CD86—multiple sclerosis	9.7e-05	0.00033	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	9.7e-05	0.000329	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	9.69e-05	0.000329	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	9.68e-05	0.000329	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	9.6e-05	0.000326	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	9.55e-05	0.000324	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	9.51e-05	0.000323	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	9.46e-05	0.000322	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	9.46e-05	0.000322	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	9.38e-05	0.000319	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—BCHE—multiple sclerosis	9.32e-05	0.000317	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	9.27e-05	0.000315	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	9.25e-05	0.000314	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	9.24e-05	0.000314	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	9.16e-05	0.000311	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	9.09e-05	0.000309	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	9.08e-05	0.000309	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	9.03e-05	0.000307	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	9.03e-05	0.000307	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	9.02e-05	0.000306	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	8.98e-05	0.000305	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	8.94e-05	0.000304	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	8.85e-05	0.000301	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	8.84e-05	0.000301	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	8.84e-05	0.000301	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	8.84e-05	0.0003	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	8.84e-05	0.0003	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	8.79e-05	0.000299	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	8.79e-05	0.000299	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—IL2—multiple sclerosis	8.78e-05	0.000298	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	8.76e-05	0.000298	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	8.75e-05	0.000297	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	8.72e-05	0.000296	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	8.66e-05	0.000294	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	8.6e-05	0.000292	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	8.6e-05	0.000292	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	8.59e-05	0.000292	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	8.59e-05	0.000292	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	8.51e-05	0.000289	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	8.48e-05	0.000288	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	8.48e-05	0.000288	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	8.43e-05	0.000286	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	8.41e-05	0.000286	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	8.39e-05	0.000285	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	8.38e-05	0.000285	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	8.35e-05	0.000284	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	8.27e-05	0.000281	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	8.26e-05	0.000281	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	8.22e-05	0.000279	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	8.21e-05	0.000279	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	8.18e-05	0.000278	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	8.14e-05	0.000277	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	8.1e-05	0.000275	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	8.08e-05	0.000275	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	8.08e-05	0.000274	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	8.05e-05	0.000273	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	7.99e-05	0.000272	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—APOE—multiple sclerosis	7.99e-05	0.000272	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	7.98e-05	0.000271	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	7.94e-05	0.00027	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—APOE—multiple sclerosis	7.83e-05	0.000266	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	7.73e-05	0.000263	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	7.66e-05	0.00026	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	7.54e-05	0.000256	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	7.52e-05	0.000256	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	7.5e-05	0.000255	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	7.45e-05	0.000253	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	7.41e-05	0.000252	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	7.38e-05	0.000251	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	7.36e-05	0.00025	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	7.34e-05	0.000249	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	7.33e-05	0.000249	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	7.31e-05	0.000248	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CD80—multiple sclerosis	7.23e-05	0.000246	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	7.18e-05	0.000244	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	7.15e-05	0.000243	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	7.15e-05	0.000243	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CD80—multiple sclerosis	7.08e-05	0.00024	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	7.04e-05	0.000239	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	7.04e-05	0.000239	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	6.98e-05	0.000237	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	6.93e-05	0.000235	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—APOE—multiple sclerosis	6.9e-05	0.000234	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—POMC—multiple sclerosis	6.87e-05	0.000233	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	6.85e-05	0.000233	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	6.84e-05	0.000232	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	6.83e-05	0.000232	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	6.82e-05	0.000232	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	6.79e-05	0.000231	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—POMC—multiple sclerosis	6.72e-05	0.000228	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	6.72e-05	0.000228	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	6.72e-05	0.000228	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	6.72e-05	0.000228	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	6.69e-05	0.000227	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	6.67e-05	0.000227	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	6.64e-05	0.000226	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	6.64e-05	0.000226	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	6.58e-05	0.000224	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	6.57e-05	0.000223	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	6.52e-05	0.000222	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	6.52e-05	0.000221	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	6.44e-05	0.000219	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	6.42e-05	0.000218	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	6.34e-05	0.000215	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	6.25e-05	0.000212	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	6.25e-05	0.000212	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	6.24e-05	0.000212	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	6.2e-05	0.000211	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	6.19e-05	0.00021	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	6.18e-05	0.00021	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	6.15e-05	0.000209	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	6.15e-05	0.000209	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	6.1e-05	0.000207	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	6.1e-05	0.000207	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	6.05e-05	0.000206	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	5.97e-05	0.000203	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	5.97e-05	0.000203	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—POMC—multiple sclerosis	5.93e-05	0.000201	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	5.88e-05	0.0002	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	5.81e-05	0.000197	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	5.77e-05	0.000196	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	5.75e-05	0.000195	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	5.72e-05	0.000194	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	5.7e-05	0.000194	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	5.68e-05	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	5.63e-05	0.000191	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APOE—multiple sclerosis	5.6e-05	0.00019	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	5.58e-05	0.00019	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	5.55e-05	0.000189	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	5.54e-05	0.000188	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	5.46e-05	0.000186	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	5.42e-05	0.000184	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ALB—multiple sclerosis	5.4e-05	0.000184	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	5.31e-05	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	5.3e-05	0.00018	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	5.22e-05	0.000177	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	5.22e-05	0.000177	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	5.19e-05	0.000176	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	5.15e-05	0.000175	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	5.13e-05	0.000174	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	5.08e-05	0.000173	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	5.08e-05	0.000172	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL2—multiple sclerosis	5.08e-05	0.000172	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	5.05e-05	0.000172	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	5.04e-05	0.000171	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	5.04e-05	0.000171	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL2—multiple sclerosis	4.97e-05	0.000169	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	4.96e-05	0.000168	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	4.95e-05	0.000168	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	4.88e-05	0.000166	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	4.85e-05	0.000165	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—POMC—multiple sclerosis	4.81e-05	0.000164	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	4.8e-05	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	4.77e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	4.74e-05	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	4.71e-05	0.00016	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	4.7e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	4.69e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	4.67e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	4.56e-05	0.000155	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	4.4e-05	0.00015	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ALB—multiple sclerosis	4.39e-05	0.000149	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	4.35e-05	0.000148	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	4.33e-05	0.000147	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	4.33e-05	0.000147	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	4.32e-05	0.000147	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	4.27e-05	0.000145	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	4.24e-05	0.000144	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	4.24e-05	0.000144	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	4.18e-05	0.000142	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	4.15e-05	0.000141	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	4.11e-05	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	4.03e-05	0.000137	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—multiple sclerosis	3.97e-05	0.000135	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	3.96e-05	0.000135	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	3.94e-05	0.000134	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	3.92e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	3.9e-05	0.000133	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—multiple sclerosis	3.89e-05	0.000132	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	3.88e-05	0.000132	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	3.88e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	3.85e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	3.85e-05	0.000131	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	3.8e-05	0.000129	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	3.71e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	3.66e-05	0.000125	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	3.66e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	3.65e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	3.61e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	3.59e-05	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	3.58e-05	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	3.47e-05	0.000118	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	3.41e-05	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	3.4e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	3.39e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	3.32e-05	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	3.3e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	3.2e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	3.19e-05	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	3.08e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	3.07e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	3.06e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	3.03e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	3.03e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	3e-05	0.000102	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—multiple sclerosis	2.98e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	2.98e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	2.96e-05	0.000101	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—multiple sclerosis	2.92e-05	9.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	2.87e-05	9.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	2.86e-05	9.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	2.82e-05	9.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	2.82e-05	9.57e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	2.81e-05	9.56e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	2.8e-05	9.52e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	2.76e-05	9.37e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	2.7e-05	9.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	2.55e-05	8.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	2.5e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	2.5e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	2.5e-05	8.49e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	2.45e-05	8.33e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	2.33e-05	7.91e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	2.32e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	2.31e-05	7.83e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	2.28e-05	7.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	2.15e-05	7.32e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	2.12e-05	7.2e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.88e-05	6.4e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	1.75e-05	5.94e-05	CbGpPWpGaD
